1. Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondria
   Damanpreet Garcha et al, 2021, Scientific Reports CrossRef
2. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues
   Simon Kind et al, 2019, Disease Markers CrossRef
3. Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1
   Péter Hollósi et al, 2020, Biomolecules CrossRef
4. Syndecans in cancer: A review of function, expression, prognostic value, and therapeutic significance
   Daniel Czarnowski, 2021, Cancer Treatment and Research Communications CrossRef
5. The Role of the Tumor Stroma in Ovarian Cancer
   Ben Davidson et al, 2014, Frontiers in Oncology CrossRef
6. Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression
   Jinfen Wei et al, 2020, International Journal of Molecular Sciences CrossRef
7. Versican in the Tumor Microenvironment
   Athanasios Papadas et al, 2020, Tumor Microenvironment CrossRef
8. Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
   Mitchell Acland et al, 2020, Frontiers in Oncology CrossRef
9. Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients
   Xiaofeng Li et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
10. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence
    Simon Kind et al, 2020, BioMed Research International CrossRef